MAIA Biotechnology, Inc.

NYSEAM:MAIA Stock Report

Market Cap: US$52.9m

MAIA Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:MAIA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Dec 24BuyUS$99,998Ramiro GuerreroIndividual53,418US$1.87
13 Dec 24BuyUS$46,800Stan SmithIndividual25,000US$1.87
01 Nov 24BuyUS$222,220Ramiro GuerreroIndividual88,534US$2.51
01 Nov 24BuyUS$55,554Steven ChaoukiIndividual22,133US$2.51
01 Nov 24BuyUS$55,554Cristian LuputIndividual22,133US$2.51
01 Nov 24BuyUS$251,000Stan SmithIndividual100,000US$2.51
25 Apr 24BuyUS$299,409Stan SmithIndividual147,492US$2.03
25 Apr 24BuyUS$39,920Ngar LouieIndividual19,665US$2.03
14 Mar 24BuyUS$8,106Ramiro GuerreroIndividual6,928US$1.17
14 Mar 24BuyUS$81,060Cristian LuputIndividual69,282US$1.17
14 Mar 24BuyUS$200,000Ngar LouieIndividual170,940US$1.17
14 Mar 24BuyUS$200,000Stan SmithIndividual170,940US$1.17
14 Mar 24BuyUS$40,530Steven ChaoukiIndividual34,641US$1.17

Insider Trading Volume

Insider Buying: MAIA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MAIA?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,469,9755.8%
Individual Insiders4,512,85817.8%
General Public19,349,23676.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.5%.

Top Shareholders

Top 25 shareholders own 23.62% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.61%
Ngar Louie
1,167,189US$2.4m0%no data
4.46%
Stan Smith
1,130,060US$2.4m12.4%no data
4.42%
Vlad Vitoc
1,119,121US$2.3m9.81%no data
2.24%
The Vanguard Group, Inc.
566,374US$1.2m5.47%no data
2.03%
Ramiro Guerrero
514,970US$1.1m61.1%no data
1.54%
Cristian Luput
389,483US$814.0k6.03%no data
1.49%
Halter Ferguson Financial, Inc.
376,714US$787.3k-47.8%0.29%
0.76%
Geode Capital Management, LLC
192,563US$402.5k22.9%no data
0.44%
Steven Chaouki
111,024US$232.0k24.9%no data
0.31%
BlackRock, Inc.
79,727US$166.6k1.54%no data
0.27%
Centric Wealth Management, LLC
68,219US$142.6k0.03%0.04%
0.18%
Bridgeway Capital Management, LLC
45,700US$95.5k0%no data
0.18%
Sergei Gryaznov
44,511US$93.0k0%no data
0.14%
State Street Global Advisors, Inc.
34,400US$71.9k0%no data
0.13%
Northern Trust Global Investments
32,071US$67.0k0%no data
0.11%
Mihail Obrocea
27,100US$56.6k0%no data
0.088%
Naviter Wealth LLC
22,168US$46.3k0%0.01%
0.066%
UBS Asset Management AG
16,685US$34.9k0%no data
0.058%
Wealth Enhancement Advisory Services, LLC
14,800US$30.9k0%no data
0.043%
XTX Holdings Limited, Asset Management Arm
10,991US$23.0k0%no data
0.037%
Joseph McGuire
9,400US$19.6k0%no data
0.02%
Morgan Stanley, Investment Banking and Brokerage Investments
5,095US$10.6k0%no data
0.011%
Lord, Abbett & Co. LLC
2,699US$5.6k91.8%no data
0.0058%
Tower Research Capital Europe Limited
1,466US$3.1k-69.1%no data
0.00062%
Bank of America Corporation, Asset Management Arm
156US$328.313.9%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 04:13
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MAIA Biotechnology, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC
Robert LeBoyerNOBLE Capital Markets, Inc.
Ashok KumarThinkEquity LLC